Ivermectin Therapy Not Efficacious in Patients With Mild COVID-19
Investigators selected patients with mild COVID-19 to receive either ivermectin or placebo to determine whether ivermectin is an efficacious treatment.
All articles by Bradley van Paridon
Repeated Influenza Vaccination Could Reduce Effectiveness
Researchers assessed the impact on pooled adjusted end-season vaccine effectiveness estimates from outpatient test-negative design studies.
Brensocatib in Bronchiectasis Patients: A Phase 2 Trial
Investigators examined whether brensocatib reduces incidence of exacerbations of bronchiectasis, reduces rate of exacerbations, or changes the concentration of active neutrophil in the sputum from baseline.
Lower Mortality With Statin Use in Hospitalized Patients With DM
Study authors assess the association between statin therapy and in-hospital mortality in patients with COVID-19 and concomitant diabetes mellitus.
ICU Care Management Challenges and Recommendations for COVID-19
The intensive care unit (ICU) community needs to prepare for the challenges associated with the coronavirus disease 2019 (COVID-19) pandemic.
Transmission of SARS-CoV-2 From Patients to Healthcare Workers
Among 121 healthcare personnel exposed to a patient with unrecognized COVID-19, 43 became symptomatic and 3 tested positive for SARS-CoV-2.
Higher Rate of Dyslipidemia Among Women Living With HIV
Despite relatively young ages, a significantly greater percentage of women living with HIV had dyslipidemia than did controls.
Higher Frequency of C albicans After Root Canals in Patients With Type 2 Diabetes
Patients with a long-term history of type 2 diabetes mellitus (T2DM) carried Candida albicans in their dental root canals more frequently when they have a primary endodontic infection.
Pathogens, Drug Resistance in People With Diabetes, Acute Cerebral Infarction and Pulmonary Infection
Multidrug-resistant gram-negative bacilli were the pathogens commonly found in patients with acute cerebral infarction complicated by diabetes mellitus and nosocomial pulmonary infection.
Direct-Acting Agents for Hepatitis C Reduce Risk for Incident Diabetes
In a large cohort of patients with HCV, the use of DAA was associated with significantly lower incidence and risk for subsequent diabetes.
- Loading...
Loading...
Next post in Diabetes
Loading... 
Loading...